BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 15, 2011
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Enigma Diagnostics, GlaxoSmithKline sales and marketing update

Enigma granted GlaxoSmithKline exclusive rights to commercialize Enigma's Enigma Mini Laboratory (ML) real-time PCR technology for point-of-care diagnostics in respiratory indications in Europe and other countries, including India, Brazil...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >